Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical Parkinsonian syndromes

International Review of Neurobiology

Volumn 90, Issue C, 2010, Pages 121-146

  Bouwmans, Angela E P ^a   Vlaar, Annemarie M M ^b   Srulijes, Karin ^c   Mess, Werner H ^a   Weber, W E J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Corticobasal degeneration; Dementia with Lewy bodies; Differential diagnosis; Idiopathic Parkinson's disease; Multiple system atrophy; Parkinsonism; Progressive supranuclear palsy; Transcranial duplex scanning; Ultrasonography

Indexed keywords

LEVODOPA;

ARTICLE; BRADYKINESIA; BRAIN THIRD VENTRICLE; CEREBELLAR ATAXIA; COGNITIVE DEFECT; CORTICOBASAL DEGENERATION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; ECHOGRAPHY; GAIT DISORDER; HUMAN; IDIOPATHIC PARKINSON DISEASE; MUSCLE RIGIDITY; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; TRANSCRANIAL SONOGRAPHY; TREMOR;

EID: 77955351608     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(10)90009-3     Document Type: Chapter

References (53)

1. Aarsland D., Rongve A., Nore S.P., Skogseth R., Skulstad S., Ehrt U., Hoprekstad D., Ballard C. Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dement. Geriatr. Cogn. Disord. 2008, 26:445-452.
2. Bachmann L.M., ter Riet G., Weber W.E., Kessels A.G. Multivariable adjustments counteract spectrum and test review bias in accuracy studies. J. Clin. Epidemiol. 2009, 62:357-361.
3. Bartova P., Skoloudik D., Fadma T., Ressner P., Kanovsky P., Herzig R. Substantia nigra evaluation in atypical parkinsonian syndromes and Parkinson's disease. Mov. Disord. 2007, 22:S142.
4. Becker G., Seufert J., Bogdahn U., Reichmann H., Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995, 45:182-184.
5. Behnke S., Berg D., Naumann M., Becker G. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J. Neurol. Neurosurg. Psychiatry 2005, 76:423-425.
6. Berg D., Godau J., Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 2008, 7:1044-1055.
7. Berg D., Siefker C., Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J. Neurol. 2001, 248:684-689.
8. Boeve B.F., Lang A.E., Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann. Neurol. 2003, 54(Suppl. 5):S15-S19.
9. Caslake R., Moore J.N., Gordon J.C., Harris C.E., Counsell C. Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J. Neurol. Neurosurg. Psychiatry 2008, 79:1202-1207.
10. Dickson D.W. Tauopathies. Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders 2006, 82-154. ISN Neuropath Press, Basel. D. Dickson (Ed.).
11. Gaenslen A., Unmuth B., Godau J., Liepelt I., Di Santo A., Schweitzer K.J., Gasser T., Machulla H.J., Reimold M., Marek K., Berg D. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol. 2008, 7:417-424.
12. Geser F., et al. Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG). Mov. Disord. 2006, 21:179-186.
13. Gilman S., et al. Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci. 1999, 163:94-98.
14. Gilman S., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
15. Hamilton R.L. Lewy bodies in Alzheimer's disease: A neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 2000, 10:378-384.
16. Hauw J.J., Daniel S.E., Dickson D., Horoupian D.S., Jellinger K., Lantos P.L., McKee A., Tabaton M., Litvan I. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994, 44:2015-2019.
17. Hughes A.J., Daniel S.E., Ben-Shlomo Y., Lees A.J. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002, 125:861-870.
18. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
19. 123 I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor. Ann. Neurol. 2003, 53:489-496.
20. Kirchhof K., Apostolidis A.N., Mathias C.J., Fowler C.J. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: A retrospective study. Int. J. Impot. Res. 2003, 15:293-298.
21. Litvan I., et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996, 46:922-930.
22. Litvan I., Grimes D.A., Lang A.E., Jankovic J., McKee A., Verny M., Jellinger K., Chaudhuri K.R., Pearce R.K. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J. Neurol. 1999, 246(Suppl. 2):II1-II5.
23. Mahapatra R.K., Edwards M.J., Schott J.M., Bhatia K.P. Corticobasal degeneration. Lancet Neurol. 2004, 3:736-743.
24. McKeith I.G., et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
25. McKeith I.G., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996, 47:1113-1124.
26. Murphy K.E., Karaconji T., Hardman C.D., Halliday G.M. Excessive dopamine neuron loss in progressive supranuclear palsy. Mov. Disord. 2008, 23:607-610.
27. Nath U., Ben-Shlomo Y., Thomson R.G., Morris H.R., Wood N.W., Lees A.J., Burn D.J. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 2001, 124:1438-1449.
28. Okawa M., Miwa H., Kajimoto Y., Hama K., Morita S., Nakanishi I., Kondo T. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. Intern. Med. 2007, 46:1527-1531.
29. Osaki Y., Ben-Shlomo Y., Lees A.J., Daniel S.E., Colosimo C., Wenning G., Quinn N. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov. Disord. 2004, 19:181-189.
30. Osaki Y., Ben-Shlomo Y., Lees A.J., Wenning G.K., Quinn N.P. A validation exercise on the new consensus criteria for multiple system atrophy. Mov. Disord. 2009, 24:2272-2276.
31. Ozawa T., et al. The alpha-synuclein gene in multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 2006, 77:464-467.
32. Sanchez-Gonzalez M.A., Garcia-Cabezas M.A., Rico B., Cavada C. The primate thalamus is a key target for brain dopamine. J. Neurosci. 2005, 25:6076-6083.
33. Schrag A., Good C.D., Miszkiel K., Morris H.R., Mathias C.J., Lees A.J., Quinn N.P. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000, 54:697-702.
34. Seppi K., Yekhlef F., Diem A., Luginger Wolf E., Mueller J., Tison F., Quinn N.P., Poewe W., Wenning G.K. Progression of parkinsonism in multiple system atrophy. J. Neurol. 2005, 252:91-96.
35. Soliveri P., Monza D., Paridi D., Carella F., Genitrini S., Testa D., Girotti F. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 2000, 69:313-318.
36. Spillantini M.G., Crowther R.A., Jakes R., Cairns N.J., Lantos P.L., Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 1998, 251:205-208.
37. Trojanowski J.Q., Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol. Appl. Neurobiol. 2007, 33:615-620.
38. Tsuboi Y., Josephs K.A., Boeve B.F., Litvan I., Caselli R.J., Caviness J.N., Uitti R.J., Bott A.D., Dickson D.W. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov. Disord. 2005, 20:982-988.
39. Vlaar A.M., Bouwmans A.E., Mess W.H., Tromp S.C., Weber W.E. Transcranial duplex in the differential diagnosis of parkinsonian syndromes: a systematic review. J. Neurol. 2009, 256:530-538.
40. Vlaar A.M., Bouwmans A.E., van Kroonenburgh M.J., Mess W.H., Tromp S.C., Wuisman P.G., Kessels A.G., Winogrodzka A., Weber W.E. Protocol of a prospective study on the diagnostic value of transcranial duplex scanning of the substantia nigra in patients with parkinsonian symptoms. BMC Neurol. 2007, 7:28.
41. Vlaar A.M., van Kroonenburgh M.J., Kessels A.G., Weber W.E. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol. 2007, 7:27.
42. Wadia P.M., Lang A.E. The many faces of corticobasal degeneration. Parkinsonism. Relat. Disord. 2007, 13(Suppl. 3):S336-S340.
43. Walker Z., Jaros E., Walker R.W., Lee L., Costa D.C., Livingston G., Ince P.G., Perry R., McKeith I., Katona C.L. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J. Neurol. Neurosurg. Psychiatry 2007, 78:1176-1181.
44. Walter U., Behnke S., Eyding J., Niehaus L., Postert T., Seidel G., Berg D. Transcranial brain parenchyma sonography in movement disorders: State of the art. Ultrasound Med. Biol. 2007, 33:15-25.
45. Walter U., Behnke S., Eyding J., Niehaus L., Postert T., Seidel G., Berg D. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med. Biol. 2007, 33:15-25.
46. Walter U., Dressler D., Probst T., Wolters A., Abu-Mugheisib M., Wittstock M., Benecke R. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch. Neurol. 2007, 64:1635-1640.
47. Walter U., Dressler D., Wolters A., Probst T., Grossmann A., Benecke R. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 2004, 63:504-509.
48. Walter U., Dressler D., Wolters A., Wittstock M., Greim B., Benecke R. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia. J. Neurol. 2006, 253:448-454.
49. Walter U., Niehaus L., Probst T., Benecke R., Meyer B.U., Dressler D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003, 60:74-77.
50. Walter U., Wittstock M., Benecke R., Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J. Neural. Transm. 2002, 109:191-196.
51. Williams D.R., de Silva R., Paviour D.C., Pittman A., Watt H.C., Kilford L., Holton J.L., Revesz T., Lees A.J. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005, 128:1247-1258.
52. Williams D.R., Holton J.L., Strand C., Pittman A., de Silva R., Lees A.J., Revesz T. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 2007, 130:1566-1576.
53. Williams D.R., Lees A.J. Progressive supranuclear palsy: Clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009, 8:270-279.